"Androgens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.
Descriptor ID |
D000728
|
MeSH Number(s) |
D27.505.696.399.472.161
|
Concept/Terms |
Androgens- Androgens
- Androgenic Compounds
- Compounds, Androgenic
- Androgen Receptor Agonists
- Agonists, Androgen Receptor
- Receptor Agonists, Androgen
- Androgenic Agents
- Agents, Androgenic
Androgen Effect- Androgen Effect
- Effect, Androgen
- Androgen Effects
- Effects, Androgen
|
Below are MeSH descriptors whose meaning is more general than "Androgens".
Below are MeSH descriptors whose meaning is more specific than "Androgens".
This graph shows the total number of publications written about "Androgens" by people in this website by year, and whether "Androgens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 3 | 0 | 3 |
1994 | 0 | 1 | 1 |
1995 | 3 | 1 | 4 |
1996 | 0 | 1 | 1 |
1997 | 0 | 4 | 4 |
1998 | 2 | 1 | 3 |
1999 | 0 | 1 | 1 |
2000 | 1 | 0 | 1 |
2001 | 1 | 2 | 3 |
2002 | 1 | 0 | 1 |
2003 | 1 | 1 | 2 |
2004 | 2 | 0 | 2 |
2005 | 4 | 3 | 7 |
2006 | 1 | 1 | 2 |
2007 | 1 | 2 | 3 |
2008 | 0 | 2 | 2 |
2009 | 1 | 4 | 5 |
2010 | 3 | 4 | 7 |
2011 | 1 | 2 | 3 |
2012 | 0 | 2 | 2 |
2013 | 2 | 1 | 3 |
2014 | 1 | 0 | 1 |
2016 | 2 | 3 | 5 |
2018 | 2 | 2 | 4 |
2020 | 0 | 1 | 1 |
2021 | 1 | 2 | 3 |
2022 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Androgens" by people in Profiles.
-
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial. Lancet. 2022 05 14; 399(10338):1886-1901.
-
Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy. JNCI Cancer Spectr. 2022 05 02; 6(3).
-
Non-Cytokine Protein Profile of the Mesenchymal Stem Cell Secretome That Regulates the Androgen Production Pathway. Int J Mol Sci. 2022 Apr 22; 23(9).
-
Characterizing zoo-housed Bactrian camel (Camelus bactrianus) reproduction using gonadal steroid metabolite analysis in feces. Domest Anim Endocrinol. 2022 07; 80:106721.
-
Normal and Premature Adrenarche. Endocr Rev. 2021 11 16; 42(6):783-814.
-
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation. Int J Radiat Oncol Biol Phys. 2022 05 01; 113(1):66-76.
-
Mesenchymal Stem Cell-Conditioned Media Regulate Steroidogenesis and Inhibit Androgen Secretion in a PCOS Cell Model via BMP-2. Int J Mol Sci. 2021 Aug 25; 22(17).
-
Group structure, but not dominance rank, predicts fecal androgen metabolite concentrations of wild male mountain gorillas (Gorilla beringei beringei). Am J Primatol. 2021 08; 83(8):e23295.
-
Current concepts of polycystic ovary syndrome pathogenesis. Curr Opin Pediatr. 2020 10; 32(5):698-706.
-
Region-specific microRNA signatures in the human epididymis. Asian J Androl. 2018 Nov-Dec; 20(6):539-544.